Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genfarma, officially Genfarma Laboratorio, is a Spanish pharmaceutical company that specializes in the development, manufacturing, and commercialization of generic medicines, with a core focus on hospital-use products and injectable formulations. Headquartered in Toledo, Spain, the company operates a sophisticated manufacturing facility capable of producing a diverse range of therapeutic agents, including anti-infectives and analgesics. In April 2021, Genfarma was acquired by Zentiva, a major European pharmaceutical group, as part of Zentiva's strategy to expand its footprint in the Iberian Peninsula and enhance its portfolio of value-added medicines. Today, Genfarma serves as a vital component of Zentiva's supply chain and commercial operations in the region, focusing on high-quality, affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genfarma.